The resolution of megaloblastic anaemias is haematological bread and butter. Since Cooper and Whitehead' documented their disconcerting findings with serum vitamin B12 levels yielded by radioisotope dilution assay (RIDA) kits, many haematologists may have sensed a crisis of confidence, amplified by similar personal experiences. Though we aspire to work with sufficient circumspection not to be thrown off course by a single erroneous result, it is not so much the ability to identify a state of vitamin B12 depletion that appears to have been lost as the grounds for its exclusion from clinical suspicion.
There is some debate about the incidence of false normal serum B12 results by RIDA, but few critics would claim a figure as high as the 20 % observed by Cooper and Whitehead. Nonetheless a disparity is noted, not only between proprietary kit systems and reference microbiological assay methods but between classical RIDA and microbiological assay methods too. These are not just trend differences, which can be accommodated for clinical purposes by modulation of the reference ranges, but sporadic disparities from otherwise reassuring co-ordinates.
Ubiquitous phenomena have been invoked to explain the disparities. Kolhouse et al.2 submitted evidence that cobalamin analogues present in plasma, which do not support the growth of Euglena gracilis or Lactobacillus leichmannii, featured as true cobalamins in some RIDA in which non-intrinsic factor 'R-binder' constituted a significant proportion of the B12 binding ingredient. However, from the evidence of their paper, cobalamin analogues are found in virtually all sera and account for about 40% of the total detectable cobalamin. Though disparities had been observed3 these were attributed to the serum extraction techniques.4
Misleading disparities are observed not only using RIDA kits. In our own experience using a classical RIDA method, we are aware of delayed diagnosis in a few subjects from whom further samples also yielded normal results. Dr Sourial's study5 does not identify cobalamin analogues by Escherichia coli. Hence 
